Lucia Longhitano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lucia Longhitano has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alessandra Romano
Hematology Section, Department of General Surgery and Medical-Surgical Specialties, University of Catania, 95123 Catania, Italy
1 shared publication - Cesarina Giallongo
Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy
1 shared publication - Daniele Tibullo
Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy
1 shared publication - Enrico La Spina
Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy
1 shared publication - Giovanni Li Volti
Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy
1 shared publication - Giuseppe Alberto Palumbo
Department of Scienze Mediche Chirurgiche e Tecnologie Avanzate “G.F. Ingrassia”, University of Catania, 95123 Catania, Italy
1 shared publication
Latest Publications
- Open Access
- 19 January 2021
- Published by MDPI AG in Biomolecules
- Vol. 11 (1) , 122
Focus on Osteosclerotic Progression in Primary Myelofibrosis
Primary myelofibrosis (PMF) is a myeloproliferative neoplasm characterized by hematopoietic stem-cell-derived clonal proliferation, leading to bone marrow (BM) fibrosis. Hematopoiesis alterations are closely associated with modifications of the BM microenvironment, characterized by defective interactions between vascular and endosteal niches. As such, neoangiogenesis, megakaryocytes hyperplasia and extensive bone marrow fibrosis, followed by osteosclerosis and bone damage, are the most relevant consequences of PMF. Moreover, bone tissue deposition, together with progressive fibrosis, represents crucial mechanisms of disabilities in patients. Although the underlying mechanisms of bone damage observed in PMF are still unclear, the involvement of cytokines, growth factors and bone marrow microenvironment resident cells have been linked to disease progression. Herein, we focused on the role of megakaryocytes and their alterations, associated with cytokines and chemokines release, in modulating functions of most of the bone marrow cell populations and in creating a complex network where impaired signaling strongly contributes to progression and disabilities.
- 19 January 2021
- Published by MDPI AG in Biomolecules
- Vol. 11 (1) , 122
Open AccessFocus on Osteosclerotic Progression in Primary Myelofibrosis
Primary myelofibrosis (PMF) is a myeloproliferative neoplasm characterized by hematopoietic stem-cell-derived clonal proliferation, leading to bone marrow (BM) fibrosis. Hematopoiesis alterations are closely associated with modifications of the BM microenvironment, characterized by defective interactions between vascular and endosteal niches. As such, neoangiogenesis, megakaryocytes hyperplasia and extensive bone marrow fibrosis, followed by osteosclerosis and bone damage, are the most relevant consequences of PMF. Moreover, bone tissue deposition, together with progressive fibrosis, represents crucial mechanisms of disabilities in patients. Although the underlying mechanisms of bone damage observed in PMF are still unclear, the involvement of cytokines, growth factors and bone marrow microenvironment resident cells have been linked to disease progression. Herein, we focused on the role of megakaryocytes and their alterations, associated with cytokines and chemokines release, in modulating functions of most of the bone marrow cell populations and in creating a complex network where impaired signaling strongly contributes to progression and disabilities.